Introduction:Basic information about CAS 1132662-08-8|Capecitabine-d11, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Capecitabine-d11 |
|---|
| CAS Number | 1132662-08-8 | Molecular Weight | 370.418 |
|---|
| Density | 1.5±0.1 g/cm3 | Boiling Point | / |
|---|
| Molecular Formula | C15H11D11FN3O6 | Melting Point | / |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
| Name | Capecitabine-d11 |
|---|
| Synonym | More Synonyms |
|---|
Capecitabine-d11 BiologicalActivity
| Description | Capecitabine-d11 is the deuterium labeled Capecitabine. Capecitabine is an oral prodrug that is converted to its active metabolite, 5-FU, by thymidine phosphorylase[1][2]. |
|---|
| Related Catalog | Signaling Pathways >>Apoptosis >>ApoptosisResearch Areas >>CancerSignaling Pathways >>Cell Cycle/DNA Damage >>DNA/RNA SynthesisSignaling Pathways >>Cell Cycle/DNA Damage >>Nucleoside Antimetabolite/Analog |
|---|
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
|---|
| References | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. PharmD CM, et al. Capecitabine: A review. Clinical Therapeutics. 2005 Jan; 27(1): 23-44. [3]. Guichard SM, et al. Gene expression predicts differential capecitabine metabolism, impacting on both pharmacokinetics and antitumour activity. Eur J Cancer. 2008 Jan;44(2):310-7. |
|---|
Chemical & Physical Properties
| Density | 1.5±0.1 g/cm3 |
|---|
| Molecular Formula | C15H11D11FN3O6 |
|---|
| Molecular Weight | 370.418 |
|---|
| Exact Mass | 370.218323 |
|---|
| PSA | 126.40000 |
|---|
| LogP | 0.97 |
|---|
| Index of Refraction | 1.600 |
|---|
| InChIKey | GAGWJHPBXLXJQN-XSFNBKHLSA-N |
|---|
| SMILES | CCCCCOC(=O)Nc1nc(=O)n(C2OC(C)C(O)C2O)cc1F |
|---|
Synonyms
| 5'-Deoxy-5-fluoro-N-{[(H)pentyloxy]carbonyl}cytidine |
| Cytidine, 5'-deoxy-5-fluoro-N-[(pentyl-d-oxy)carbonyl]- |
| 1,1,2,2,3,3,4,4,5,5,5-undecadeuteriopentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate |